Display options
Cite
Mahgoub A, Steer CJ. MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases. J Clin Med. 2016;5(5)doi: 10.3390/jcm5050052.
Mahgoub, A., & Steer, C. J. (2016). MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases. Journal of clinical medicine, 5(5), . https://doi.org/10.3390/jcm5050052
Mahgoub, Amar, and Steer, Clifford J. "MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases." Journal of clinical medicine vol. 5,5 (2016). doi: https://doi.org/10.3390/jcm5050052
Mahgoub A, Steer CJ. MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases. J Clin Med. 2016 May 10;5(5). doi: 10.3390/jcm5050052. PMID: 27171116; PMCID: PMC4882481.
Copy Download .nbib Format: NLM
Share it on

J Clin Med. 2016 May 10;5(5). doi: 10.3390/jcm5050052.

MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases.

Journal of clinical medicine

Amar Mahgoub, Clifford J Steer

Affiliations

  1. Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota Medical School, Veterans of Foreign Wars Cancer Research Center, 406 Harvard Street, S.E., Minneapolis, MN 55455, USA. [email protected].
  2. Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota Medical School, Veterans of Foreign Wars Cancer Research Center, 406 Harvard Street, S.E., Minneapolis, MN 55455, USA. [email protected].
  3. Department of Genetics, Cell Biology and Development, University of Minnesota Medical School, Veterans of Foreign Wars Cancer Research Center, 406 Harvard Street, S.E., Minneapolis, MN 55455, USA. [email protected].

PMID: 27171116 PMCID: PMC4882481 DOI: 10.3390/jcm5050052

Abstract

Acute and chronic liver disease continue to result in significant morbidity and mortality of patients, along with increasing burden on their families, society and the health care system. This in part is due to increased incidence of liver disease associated factors such as metabolic syndrome; improved survival of patients with chronic predisposing conditions such as HIV; as well as advances in the field of transplantation and associated care leading to improved survival. The fact that one disease can result in different manifestations and outcomes highlights the need for improved understanding of not just genetic phenomenon predisposing to a condition, but additionally the role of epigenetic and environmental factors leading to the phenotype of the disease. It is not surprising that providers continue to face daily challenges pertaining to diagnostic accuracy, prognostication of disease severity, progression, and response to therapies. A number of these challenges can be addressed by incorporating a personalized approach of management to the current paradigm of care. Recent advances in the fields of molecular biology and genetics have paved the way to more accurate, individualized and precise approach to caring for liver disease. The study of microRNAs and their role in both healthy and diseased livers is one example of such advances. As these small, non-coding RNAs work on fine-tuning of cellular activities and organ function in a dynamic and precise fashion, they provide us a golden opportunity to advance the field of hepatology. The study of microRNAs in liver disease promises tremendous improvement in hepatology and is likely to lay the foundation towards a personalized approach in liver disease.

Keywords: NAFLD; NASH; acute liver failure; biogenesis; epigenetics; hepatitis; hepatocellular carcinoma; liver diseases; liver regeneration; metabolic liver diseases; microRNAs; non-coding RNAs; partial hepatectomy; personalized medicine; systems biology

References

  1. Liver Int. 2014 Feb;34(2):281-95 - PubMed
  2. Mol Pharmacol. 2011 Jul;80(1):191-200 - PubMed
  3. Bioinformatics. 2015 May 1;31(9):1502-4 - PubMed
  4. Mol Cell. 2011 Sep 16;43(6):892-903 - PubMed
  5. Semin Liver Dis. 2015 Feb;35(1):12-25 - PubMed
  6. Comp Hepatol. 2012 Nov 20;11(1):3 - PubMed
  7. Hepatol Int. 2012 Oct;6(4):770-7 - PubMed
  8. Hepatology. 2011 Aug;54(2):609-19 - PubMed
  9. Clin Cancer Res. 2008 Jan 15;14(2):419-27 - PubMed
  10. Br J Surg. 2002 Sep;89(9):1089-95 - PubMed
  11. FASEB J. 1995 Nov;9(14):1396-400 - PubMed
  12. Science. 2010 Jun 18;328(5985):1570-3 - PubMed
  13. Liver. 2002 Oct;22(5):419-25 - PubMed
  14. J Viral Hepat. 2013 Mar;20(3):158-66 - PubMed
  15. Clin Gastroenterol Hepatol. 2012 Jun;10 (6):646-50 - PubMed
  16. Semin Liver Dis. 2015 Feb;35(1):3-11 - PubMed
  17. Hepatology. 2009 Apr;49(4):1098-112 - PubMed
  18. Hepatology. 2012 Mar;55(3):730-41 - PubMed
  19. Cancer Cell. 2009 Dec 8;16(6):498-509 - PubMed
  20. J Gastroenterol. 2015 Oct;50(10 ):1027-40 - PubMed
  21. FEBS Lett. 2011 Mar 23;585(6):927-34 - PubMed
  22. J Hepatol. 2013 Apr;58(4):785-91 - PubMed
  23. Bioessays. 2010 Jul;32(7):599-608 - PubMed
  24. PLoS One. 2012;7(6):e39151 - PubMed
  25. Mol Biol Cell. 2008 Aug;19(8):3272-82 - PubMed
  26. PLoS One. 2010 Jun 30;5(6):e11387 - PubMed
  27. Nucleic Acids Res. 2008 Mar;36(4):1153-62 - PubMed
  28. Nucleic Acids Res. 2014 Jan;42(Database issue):D68-73 - PubMed
  29. Genes Dev. 2010 May 15;24(10):992-1009 - PubMed
  30. Am J Physiol Gastrointest Liver Physiol. 2010 Oct;299(4):G887-97 - PubMed
  31. Sci Rep. 2015 Sep 02;5:13729 - PubMed
  32. Transpl Int. 2016 Mar;29(3):369-80 - PubMed
  33. EMBO J. 2012 Jan 4;31(1):110-23 - PubMed
  34. J Hepatol. 2013 Jan;58(1):119-25 - PubMed
  35. Trends Cell Biol. 2008 Oct;18(10):505-16 - PubMed
  36. Gastroenterology. 2010 Sep;139(3):999-1007, 1007.e1-2 - PubMed
  37. Hepatology. 2004 Nov;40(5):1098-105 - PubMed
  38. Gastroenterology. 2011 Mar;140(3):1009-20 - PubMed
  39. RNA Biol. 2004 Jul;1(2):106-13 - PubMed
  40. Am J Transplant. 2013 May;13(5):1282-95 - PubMed
  41. Dev Cell. 2010 Feb 16;18(2):175-89 - PubMed
  42. Hepatology. 2010 Oct;52(4):1431-42 - PubMed
  43. Hepatology. 2010 May;51(5):1735-43 - PubMed
  44. Reprod Sci. 2015 Aug;22(8):1037-41 - PubMed
  45. Sci Rep. 2015 Jun 25;5:11590 - PubMed
  46. J Clin Invest. 2012 Mar;122(3):1097-108 - PubMed
  47. PLoS One. 2015 Nov 17;10(11):e0136908 - PubMed
  48. Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24 - PubMed
  49. Hepatology. 2008 Jun;47(6):1994-2002 - PubMed
  50. Biochem Biophys Res Commun. 2014 Jan 17;443(3):802-7 - PubMed
  51. J Cell Physiol. 2007 Nov;213(2):286-300 - PubMed
  52. Genome Biol. 2011;12(4):221 - PubMed
  53. J Biol Chem. 2009 Nov 13;284(46):31921-7 - PubMed
  54. World J Gastroenterol. 2012 Dec 7;18(45):6546-51 - PubMed
  55. Cell Physiol Biochem. 2015;37(2):615-28 - PubMed
  56. Nature. 2010 Jun 3;465(7298):584-9 - PubMed
  57. Cancer Lett. 2014 Sep 1;351(2):265-71 - PubMed
  58. Ann N Y Acad Sci. 2002 Dec;981:82-96 - PubMed
  59. EMBO J. 2002 Sep 2;21(17):4663-70 - PubMed
  60. Science. 1997 Apr 4;276(5309):60-6 - PubMed
  61. Hepatology. 2014 Oct;60(4):1346-55 - PubMed
  62. Proc Natl Acad Sci U S A. 2011 May 31;108(22):9232-7 - PubMed
  63. Genes Chromosomes Cancer. 2001 Aug;31(4):345-56 - PubMed
  64. PLoS One. 2012;7(4):e33577 - PubMed
  65. Hepatology. 2013 Jan;57(1):299-310 - PubMed
  66. Hepatology. 2009 Sep;50(3):844-51 - PubMed
  67. PLoS One. 2012;7(9):e44737 - PubMed
  68. Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):264-9 - PubMed
  69. Nucleic Acids Res. 2012 Jan;40(2):884-91 - PubMed
  70. Nucleic Acids Res. 2008 Oct;36(18):5727-35 - PubMed
  71. Lancet. 2003 Dec 6;362(9399):1907-17 - PubMed
  72. Cell. 2004 Jan 23;116(2):281-97 - PubMed
  73. Hepatology. 2014 Sep;60(3):964-76 - PubMed
  74. Hepatology. 2014 Apr;59(4):1617-26 - PubMed
  75. Cancer Cell. 2011 Feb 15;19(2):232-43 - PubMed
  76. Hepatogastroenterology. 2012 Jan-Feb;59(113):235-40 - PubMed
  77. Int J Biochem Cell Biol. 2014 Sep;54:288-303 - PubMed
  78. Onkologie. 2012;35 Suppl 1:4-7 - PubMed
  79. Cancer Res. 2005 Jun 15;65(12):5301-9 - PubMed
  80. Gastroenterology. 2007 Aug;133(2):647-58 - PubMed
  81. Trends Endocrinol Metab. 2014 Mar;25(3):138-45 - PubMed
  82. Hepatology. 2014 Aug;60(2):736-43 - PubMed
  83. World J Gastroenterol. 2013 Aug 28;19(32):5212-26 - PubMed
  84. Clin Res Hepatol Gastroenterol. 2011 Oct;35(10):623-9 - PubMed
  85. Gastroenterology. 2012 Jun;142(7):1431-43 - PubMed
  86. J Virol. 2013 May;87(9):5270-86 - PubMed
  87. Clin Chem. 2010 Nov;56(11):1733-41 - PubMed
  88. Hepatology. 2008 Dec;48(6):1810-20 - PubMed
  89. Nat Rev Cancer. 2006 Nov;6(11):857-66 - PubMed
  90. Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R207-14 - PubMed
  91. Adv Nutr. 2010 Nov;1(1):8-16 - PubMed
  92. Science. 2005 Sep 2;309(5740):1577-81 - PubMed
  93. Semin Liver Dis. 1999;19(2):117-27 - PubMed
  94. Semin Liver Dis. 2015 Feb;35(1):43-54 - PubMed
  95. PLoS One. 2009 Sep 01;4(9):e6880 - PubMed
  96. Gut. 2015 May;64(5):800-12 - PubMed
  97. Dev Biol. 2007 Feb 1;302(1):1-12 - PubMed
  98. Hepatology. 2016 Jul;64(1):73-84 - PubMed
  99. J Cell Mol Med. 2008 Dec;12(6A):2189-204 - PubMed
  100. Nat Rev Clin Oncol. 2014 Mar;11(3):145-56 - PubMed
  101. Nature. 2013 Oct 24;502(7472):513-8 - PubMed
  102. Expert Rev Gastroenterol Hepatol. 2011 Feb;5(1):105-21 - PubMed
  103. Am J Respir Crit Care Med. 2014 Feb 1;189(3):263-73 - PubMed
  104. Gastroenterology. 2007 Jun;132(7):2557-76 - PubMed
  105. Cell. 2009 Jan 23;136(2):215-33 - PubMed
  106. Exp Biol Med (Maywood). 2014 Oct;239(10):1275-9 - PubMed
  107. Mol Cell Biol. 2000 Aug;20(16):6127-37 - PubMed
  108. Hepatology. 2009 Feb;49(2):618-26 - PubMed
  109. FEBS J. 2014 Jun;281(11):2503-24 - PubMed
  110. Cancer Cell. 2006 Jun;9(6):435-43 - PubMed
  111. Mol Diagn Ther. 2014 Jun;18(3):273-84 - PubMed
  112. Cell. 2009 Feb 20;136(4):629-41 - PubMed
  113. PLoS One. 2008;3(10):e3574 - PubMed
  114. World J Hepatol. 2015 Oct 28;7(24):2497-502 - PubMed
  115. Hepatol Res. 2011 Feb;41(2):170-83 - PubMed
  116. Oncol Rep. 2014 Jul;32(1):97-104 - PubMed
  117. Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R17-29 - PubMed
  118. Mol Med Rep. 2013 Jul;8(1):287-93 - PubMed
  119. Mol Oncol. 2012 Aug;6(4):445-57 - PubMed

Publication Types